AU2005288710A1 - Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis - Google Patents

Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis

Info

Publication number
AU2005288710A1
AU2005288710A1 AU2005288710A AU2005288710A AU2005288710A1 AU 2005288710 A1 AU2005288710 A1 AU 2005288710A1 AU 2005288710 A AU2005288710 A AU 2005288710A AU 2005288710 A AU2005288710 A AU 2005288710A AU 2005288710 A1 AU2005288710 A1 AU 2005288710A1
Authority
AU
Australia
Prior art keywords
assays
diagnosis
methods
amino acid
acid sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005288710A
Other versions
AU2005288710A2 (en
Inventor
Pinchas Akiva
Michal Ayalon-Soffer
Lily Bazak
Yossi Cohen
Gad S. Coljocaru
Dvir Dahary
Alexander Diber
Arial Farkash
Guy Kol
Sergey Nemzer
Amit Novik
Sarah Pollock
Osnat Sella-Tavor
Zipi Shaqed
Ronen Shemesh
Maxim Shklar
Rotem Sorek
Amir Toporik
Levine Zurit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Compugen Ltd
Original Assignee
Compugen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Compugen Ltd filed Critical Compugen Ltd
Priority claimed from US11/043,788 external-priority patent/US20060014166A1/en
Publication of AU2005288710A1 publication Critical patent/AU2005288710A1/en
Publication of AU2005288710A2 publication Critical patent/AU2005288710A2/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU2005288710A 2004-01-27 2005-01-27 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis Abandoned AU2005288710A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
USNOTGIVEN 2002-04-17
US53912904P 2004-01-27 2004-01-27
US60/539,129 2004-01-27
US62866604P 2004-11-18 2004-11-18
US60/628,666 2004-11-18
US11/043,788 US20060014166A1 (en) 2004-01-27 2005-01-27 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of endometriosis
PCT/IB2005/002438 WO2006035273A2 (en) 2004-01-27 2005-01-27 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis

Publications (2)

Publication Number Publication Date
AU2005288710A1 true AU2005288710A1 (en) 2006-04-06
AU2005288710A2 AU2005288710A2 (en) 2006-04-06

Family

ID=36119256

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005288710A Abandoned AU2005288710A1 (en) 2004-01-27 2005-01-27 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis

Country Status (4)

Country Link
EP (1) EP1716256A2 (en)
AU (1) AU2005288710A1 (en)
CA (1) CA2554718A1 (en)
WO (1) WO2006035273A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114835812A (en) 2008-12-09 2022-08-02 霍夫曼-拉罗奇有限公司 anti-PD-L1 antibodies and their use for enhancing T cell function

Also Published As

Publication number Publication date
WO2006035273A2 (en) 2006-04-06
EP1716256A2 (en) 2006-11-02
CA2554718A1 (en) 2006-04-06
AU2005288710A2 (en) 2006-04-06
WO2006035273A3 (en) 2009-04-16

Similar Documents

Publication Publication Date Title
WO2006131928A3 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
IL172297A0 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis iii
WO2006054297A3 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
EP1973945A4 (en) Novel nucleotide and amino acid sequences, and methods of use thereof for diagnosis
WO2005014850A3 (en) Systems and methods for analyzing nucleic acid sequences
AU2002255478A1 (en) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
WO2005084116A3 (en) Calcium channel variants
WO2008143668A3 (en) Indoleamine-2, 3-dioxygenase-2
WO2005087951A3 (en) Reagents, methods and kits for use in deactivating nucleic acids
PT1922415E (en) Use of both rd9 and is6110 as nucleic acid targets for the diagnosis of tuberculosis, and provision of multiplex-compliant is6110 and rd9 targets
EP1954826A4 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
EP1774046A4 (en) Novel nucleotide and amino acid sequences and assays and methods of use thereof for diagnosis of lung cancer
WO2005072053A9 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of colon cancer
WO2005072050A9 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
AU2005288710A1 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
IL174465A0 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
IL187946A0 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
EP1762611A4 (en) Nucleic acid/enzyme complex
AU2002953431A0 (en) BmpB Novel Nucleotide and Amino Acid Sequences and Diagnostic and Therapeutic Uses Thereof
WO2006018259A3 (en) Method of screening for a carnitine transporter agonist or antagonist and its uses
IL172460A0 (en) Novel nucleotide acid sequences, and assays and methods of use thereof for diagnosis
IL177215A0 (en) Novel nucleotide acid sequences, and assays and methods of use thereof for diagnosis
IL173173A0 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
EP1714976A4 (en) Amino acid sequences from active principle of musk and their acetic salt, also the preparation and usage
IL172204A0 (en) Novel nucleic acid sequences, and assays and methods of use thereof for diagnosis

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 14 AUG 2007

NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO REQUEST EXAMINATION HAS BEEN EXTENDED TO 13 SEP 2007.

MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application